ECB's Guindos Says Euro Gain Past $1.20 Would Be Complicated
In rare remarks by an ECB official on the common currency's exchange rate, Guindos told Bloomberg TV that the speed of the euro's ascent is more worrying than its current level.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Butterfly Network, Inc. (BFLY) Gains Analyst Confidence Amid EU Review
Butterfly Network, Inc. (NYSE:BFLY) is among the best growth stocks to invest in for the next 5 years. Analysts at TD Cowen reaffirmed their Buy rating on Butterfly Network, Inc. (NYSE:BFLY), with an unchanged price target of $5.00, signaling an upside of around 150% from the current levels. This optimism stems from the European Commission's launch of a review period regarding the company's proposal to withdraw its EU market exemption. Currently, the exemption protects the continued use of lead piezoelectric crystals in portable ultrasound devices. The initiation marks a crucial moment in the company's efforts to remove the market exemption for lead piezoelectric crystals, which are considered important for several handheld ultrasound devices. Having said that, public feedback will be accepted through August 1, with an expected recommendation to the European Commission by the second quarter of the upcoming fiscal year. A doctor looking at a ultrasound system with a Compass software interface, demonstrating the sophistication of the device. From expanding the target market for the company's technologies to accelerating growth in the existing challenging market, the significance of this development can't be denied. While the final decision is anticipated in the years ahead, investors are closely monitoring the company's position as the decision in favor of Butterfly Network, Inc. (NYSE:BFLY) would set the stage for future growth. Butterfly Network, Inc. (NYSE:BFLY) is a Massachusetts-based company that develops and markets ultrasound imaging solutions globally. The core offerings of the company include Butterfly iQ+ and iQ3 ultrasound devices, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet. Incorporated in 2011, the giant is working to democratize medical imaging by making it accessible to everyone. While we acknowledge the potential of BFLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Bloomberg
29 minutes ago
- Bloomberg
An Appealing, Cheap Alternative to Private Equity
Welcome to the award-winning Money Distilled newsletter. I'm John Stepek. Every week day I look at the biggest stories in markets and economics, and explain what it all means for your money. Today I'm hosting my colleague Merryn Somerset Webb, to whose fantastic podcast (including the episodes I'm not in) you should subscribe immediately — Apple folk can subscribe here; fellow Android users, try Spotify, or just the podcast app of your choice. Take it away Merryn...
TechCrunch
an hour ago
- TechCrunch
EU says it will continue rolling out AI legislation on schedule
The European Union on Friday said it will stick to its timeline for implementing its landmark AI legislation, in response to a concerted effort by over a hundred tech companies to delay the bloc's AI rules, Reuters reported. Tech companies from across the world, including giants like Alphabet, Meta, Mistral AI and ASML have been urging the European Commission to delay rolling out the AI Act, saying it will hurt Europe's chances to compete in the fast-evolving AI arena. 'I've seen, indeed, a lot of reporting, a lot of letters and a lot of things being said on the AI Act. Let me be as clear as possible, there is no stop the clock. There is no grace period. There is no pause,' the report cited European Commission spokesperson Thomas Regnier as saying. A risk-based regulation for applications of artificial intelligence, the AI Act bans a handful of 'unacceptable risk' use cases outright, such as cognitive behavioral manipulation or social scoring. It also defines a set of 'high-risk' uses, such as biometrics and facial recognition, or AI used in domains like education and employment. App developers will need to register their systems and meet risk and quality management obligations to gain access to the EU market. Another category of AI apps, such as chatbots, are considered 'limited risk' and subject to lighter transparency obligations. The EU started rolling out the AI Act last year in a staggered fashion, with the full rules coming into force by mid-2026.
